TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
5/19/2008 7:49:59 AM
More...
|
Shire Pharmaceuticals Group plc (SHPGY) and TAP Pharmaceutical Products Inc. Agree to Co-promote LIALDA(TM) (mesalamine), the First Oral Once-Daily Mesalamine For Patients With Active, Mild to Moderate Ulcerative Colitis
3/26/2008 11:38:20 AM
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) to Pay Abbott Laboratories (ABT) up to $1.5B in Venture Split
3/20/2008 6:29:35 AM
More...
|
TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
1/4/2008 7:59:54 AM
More...
|
Out at Work: Diversity in the Pharmaceutical and Biotechnology Industries
6/29/2007 7:29:19 PM
More...
|
Takeda Pharmaceuticals North America, Inc. and TAP Pharmaceutical Products Inc. to Promote Sucampo Pharmaceuticals, Inc.'s AMITIZA(R) in the United States
2/26/2007 12:03:54 PM
More...
|
First French Pharma To Fully Automate Cell Culture Chooses CompacT SelecT™ From The Automation Partnership
11/29/2006 1:07:47 PM
More...
|
Novartis Corporation (NVS) And TAP Pharmaceutical Products Inc. To Co-Promote Genital Herpes Drug
9/29/2006 9:10:23 AM
More...
|
FDA Refuses Again To Approve TAP Pharmaceutical Products Inc.'s Gout Drug
8/14/2006 8:24:49 AM
More...
|
TAP Pharmaceutical Products Inc. Release: Second Annual Kids Create. Parents Relate. National Drawing And Coloring Contest Kicks-Off To Help Raise Awareness Of Pediatric GERD
6/14/2006 10:36:21 AM
More...
|
|